Third quarter results highlight strong operational performance across key value drivers: YUPELRI® (revefenacin) net sales of $62.2 million, recognized by Viatris ...

Gilead Sciences, Inc. today presented the first in-depth look at full results from its pivotal Phase 3 PURPOSE 2 trial (NCT04925752), which is studying twice-yearly lenacapavir, the company's ...

Trailblazers like Nathalie Verdeille and Claire Choisne are redefining timeless jewellery with fresh perspectives and ...

Starting on Nov. 15, 2024, X will use everything you post to train its AI. Here's how to deactivate your X account.

The classic Ajax logo will officially return as the club's emblem starting from season 2025/2026. As a result, the classic ...

Key inputs include: No matter which approach you take for deriving royalty rates, one of the key considerations is how to handle the number of documents and amount of data your company will ...

Here’s what you need to know about Trump's housing policy.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The growth of the Oilfield Stimulation Chemicals Market is driven by several key factors. The increasing demand for enhanced oil recovery techniques and the need to maximize production from mature ...